| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/2008 | US20080031835 Antiinflammatory And Analgesic Preparation For External Use |
| 02/07/2008 | US20080031828 Method for the Treatment of Dyspnea Comprising Combined Administration of Tiotropium Salts and Salts of Salmeterol |
| 02/07/2008 | US20080031827 Injectables in foam. New Pharmaceutical applications |
| 02/07/2008 | US20080031826 Devices containing lipid emulsions |
| 02/07/2008 | US20080031825 Pharmaceutical Compositions Comprising Effervescent Agents And Fenofibrate |
| 02/07/2008 | US20080031824 Swellable particles for drug delivery |
| 02/07/2008 | US20080029393 Valve for controlling flow of a fluid |
| 02/07/2008 | US20080029084 Device for improved peptide delivery |
| 02/07/2008 | US20080029083 Ejection liquid and ejection method |
| 02/07/2008 | CA2660029A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 02/07/2008 | CA2659948A1 Compositions of microparticles and granules for oral controlled release of substances for veterinary use |
| 02/07/2008 | CA2659880A1 Metallic nanoparticles and uses thereof as antimicrobials |
| 02/07/2008 | CA2659846A1 Parathyroid hormone analogues and methods of use |
| 02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | CA2659523A1 Multilayer orally disintegrating tablet |
| 02/07/2008 | CA2659441A1 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | CA2659440A1 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | CA2659390A1 Liquid preparation |
| 02/07/2008 | CA2659330A1 Nanoparticle drug formulations |
| 02/07/2008 | CA2659122A1 Granule and orally disintegrating tablet comprising oxycodone |
| 02/07/2008 | CA2658592A1 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | CA2657392A1 Gastro retentive delivery system |
| 02/07/2008 | CA2655682A1 Delayed-release glucocorticoid treatment of rheumatoid disease |
| 02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 02/07/2008 | CA2596153A1 Rimonabant-containing pharmaceutical preparation |
| 02/06/2008 | EP1884242A1 Pharmaceutical composition |
| 02/06/2008 | EP1884241A1 A oral preparation comprising dyclonine hydrochloride |
| 02/06/2008 | EP1884234A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder |
| 02/06/2008 | EP1884233A1 Method of marking composition for oral administration |
| 02/06/2008 | EP1884232A1 Method of producing liposomes containing gas enclosed therein |
| 02/06/2008 | EP1883519A2 Hydrogel constructs using stereolithography |
| 02/06/2008 | EP1883446A2 An implantable therapy system for treating a living being with an active factor |
| 02/06/2008 | EP1883418A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 02/06/2008 | EP1883408A2 Solid compositions and methods for treating middle-of-the night insomnia |
| 02/06/2008 | EP1883406A2 Compositions and methods for the sustained release of beta-alanine |
| 02/06/2008 | EP1883400A1 Inhalator capsules |
| 02/06/2008 | EP1883398A2 Method and device for selective addition of a bioactive agent to a multi-phase implant |
| 02/06/2008 | EP1883397A2 Dispersible bosertan tablet |
| 02/06/2008 | EP1883396A1 Colonic delivery of adsorbents |
| 02/06/2008 | EP1883395A2 Lipid construct for delivery of interferon to a mammal |
| 02/06/2008 | EP1883394A2 Lipid construct for delivery of insulin to a mammal |
| 02/06/2008 | EP1883393A2 Stabilized oral pharmaceutical compositions of cephalosporins |
| 02/06/2008 | EP1883392A2 Process for preparation of isotonic aqueous injection of ropivacaine |
| 02/06/2008 | EP1883391A2 Epidermal growth factor composition, a process therefor and its application |
| 02/06/2008 | EP1883390A2 Topical compositions |
| 02/06/2008 | EP1883317A2 Dosage form for oral administration of a vitamin |
| 02/06/2008 | EP1883304A1 Process for treating animal waste |
| 02/06/2008 | CN201015652Y Skin burn concrescence paste |
| 02/06/2008 | CN101119747A Tissue factor production inhibitor |
| 02/06/2008 | CN101119733A Method for reducing or avoiding adverse effect of steroid compound |
| 02/06/2008 | CN101119730A Ointment |
| 02/06/2008 | CN101119720A Compositions containing polysaccharides |
| 02/06/2008 | CN101119716A External plaster containing flurbiprofen |
| 02/06/2008 | CN101119712A Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof |
| 02/06/2008 | CN101119711A Method of use herbal compositions |
| 02/06/2008 | CN101119710A High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
| 02/06/2008 | CN101119709A Orally bioavailable cci-779 formulations |
| 02/06/2008 | CN101119708A Bendamustine pharmaceutical compositions |
| 02/06/2008 | CN101119707A Lyophilization of virosomes |
| 02/06/2008 | CN101119706A Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 02/06/2008 | CN101119705A Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPF-inhibitor for the treatment of central nervous system-related conditions |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds |
| 02/06/2008 | CN101116737A Method for preparing traditional Chinese medicine for treating coronary disease |
| 02/06/2008 | CN101116733A Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis |
| 02/06/2008 | CN101116727A Yang-establishing yin-nourishing ointment |
| 02/06/2008 | CN101116722A Pharmaceutical formulations with the raw material containing panax, ophiopogon root and schisandra fruit, processes for their preparation, the raw material and the quality control method for the prepa |
| 02/06/2008 | CN101116721A Lily relaxing Chinese traditional medicine pills good for sleep |
| 02/06/2008 | CN101116713A Cactus aloe anticancer capsule and method for preparing the same |
| 02/06/2008 | CN101116706A Calculus eliminating powder |
| 02/06/2008 | CN101116684A Mongolian medicine for treating cerebrovascular disease |
| 02/06/2008 | CN101116681A Rheum fever allaying tables and method for preparing the same |
| 02/06/2008 | CN101116680A Chinese traditional medicine preparation for curing laryngopharyngitis |
| 02/06/2008 | CN101116677A Compound milettia reticulata capsule and method for preparing the same |
| 02/06/2008 | CN101116676A Method for preparing compound milettia reticulata particles |
| 02/06/2008 | CN101116674A Mongolian medicine for treating bone fracture |
| 02/06/2008 | CN101116673A Middle gut positioning sausage dissolvable pharmaceutical formulations for relieving diarrhea and processes for their preparation |
| 02/06/2008 | CN101116670A Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis |
| 02/06/2008 | CN101116668A Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples |
| 02/06/2008 | CN101116667A Medicine for treating and preventing immune abnormalism disease |
| 02/06/2008 | CN101116665A Malaria-resisting arteannuin naphthoquine compound composition |
| 02/06/2008 | CN101116659A Eplerenone soft capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116658A Eplerenone liquid capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116657A Externally- used contraception emulsion and method for preparing the same |
| 02/06/2008 | CN101116656A Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
| 02/06/2008 | CN100366621C Plumepoppy total alkaloid salt and its prepn and application |
| 02/06/2008 | CN100366305C Transcutaneous delivery means |
| 02/06/2008 | CN100366296C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 02/06/2008 | CN100366295C Composition for intestinal delivery |
| 02/06/2008 | CN100366294C Oral cavity quick dissolving preparation and production method thereof |
| 02/06/2008 | CN100366292C Recombinant porcine adenovirus vector |
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366285C Medicine, and its preparing method and use for treating arthritis by external application |
| 02/06/2008 | CN100366280C Medicinal composition for treating hypertension, its preparation method and use |
| 02/06/2008 | CN100366277C Medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 02/06/2008 | CN100366268C Plant essence with equalized fat acids |
| 02/06/2008 | CN100366262C A medicine for treating dermatosis, venereal diseases, cancer and AIDS and preparation method thereof |
| 02/06/2008 | CN100366260C Astragalus glycoside fatty emulsion and its preparation technology |
| 02/06/2008 | CN100366256C Ciclesonide-containing sterile aqueous suspension |